デフォルト表紙
市場調査レポート
商品コード
1475016

医薬品包装材料の世界市場の評価:包装タイプ別、原材料別、ドラッグデリバリー別、エンドユーザー別、地域別、機会、予測(2017年~2031年)

Pharma Packaging Materials Market Assessment, By Packaging Type, By Raw Material, By Drug Delivery, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日: | 発行: Market Xcel - Markets and Data | ページ情報: 英文 233 Pages | 納期: 3~5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.10円
医薬品包装材料の世界市場の評価:包装タイプ別、原材料別、ドラッグデリバリー別、エンドユーザー別、地域別、機会、予測(2017年~2031年)
出版日: 2024年05月08日
発行: Market Xcel - Markets and Data
ページ情報: 英文 233 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の医薬品包装材料の市場規模は、2023年の1,216億1,000万米ドルから2031年に2,616億3,000万米ドルに達すると予測され、予測期間の2024年~2031年にCAGRで10.1%の成長が見込まれます。市場の成長は、製薬部門の拡大と医療部門における支出の増加によるものと考えられます。

医薬品や投薬に対する要求の高まりは、医薬品包装材料に対する要求を強化する主な要因です。例えば、2023年11月にレビューされた疾病管理予防センターの推計によると、医師の診察の約71.9%が薬物療法に関与しており、約10億の医薬品が処方されています。頻繁に処方される治療薬には、ビタミン剤、鎮痛剤、抗高脂血症剤などがあります。このような要求の高まりが、医薬品包装材料の需要を高めています。医薬品包装に対するFDAのようなさまざまな規制機関の厳格化は、医薬品包装材料への投資を強化し、その結果、市場の拡大にプラスの影響を与えています。

環境上の懸念の高まりにより、持続可能な医薬品包装材料の開発が重視されるようになり、市場の拡大を支えています。技術的にリサイクル可能な医薬品包装材料を開発しようとするさまざまなメーカーの活動の活発化も、市場成長をさらに促進しています。

例えば、リサイクル困難な廃棄物の回収と再利用のグローバルリーダーであるTerraCycleは、HoneywellのAclar Barrier Film BlistersをPETGとPVCベースのブリスターで技術的にリサイクル可能であると認定しました。このフィルムはライフサイエンスポートフォリオの一部であり、安定性を確保するために水分バリア保護をもたらすことで医薬品の効能を維持し、医薬品の保護に役立っています。このような成果は、医薬品ブリスター包装のような多層材料をリサイクルする手法をもたらし、市場の拡大を支えています。

医療・製薬部門の拡大が市場の成長を後押し

製薬・医療部門への投資の増加は、製造プロセスや技術革新の進歩とともに、市場に有利な成長機会をもたらしています。例えばInvest Indiaは、インドの病院部門の売上が2027年度までに2,192億米ドルに達すると推定しています。この成長により、医薬品包装材料の需要が高まり、市場の拡大が見込まれます。

医療部門の成長は、主要企業による投資の増加、医療システムによって提供されるさまざまな利点に関する意識の高まり、所得水準の上昇、健康管理の重視によるものと考えられます。このような成長により、医薬品の利用が増加し、医薬品包装材料の需要が高まっています。さまざまな疾患や障害の流行が、医薬品や投薬、とりわけ医薬品供給への要求をさらに押し上げ、医薬品包装材料への需要の増加をもたらしています。これらの要因が市場の成長に大きく寄与しています。

持続可能な医薬品包装の開発の重視が、市場に有利な成長機会をもたらす

世界中のさまざまな製薬企業や医療企業は、カーボンフットプリントを削減し、包装サプライチェーン全体におけるプラスチックへの依存を減らすために、包括的な持続可能性包装プログラムを開発しています。環境意識の高まりから、環境にやさしい包装製品に対する消費者の需要が増加しており、製薬企業が持続可能な包装ソリューションを採用し、消費者に環境にやさしい代替品を提供することをさらに後押ししています。持続可能な包装ソリューションに対する需要の増加に対応するため、さまざまな主要製薬企業は、包装によって引き起こされる環境への悪影響を低減するための提携への投資を強化しています。このような提携や取り組みが、市場に有利な成長機会をもたらしています。

さらに、環境に対する懸念の高まりから、医療機器や医薬品包装の主要プロバイダーは、100%再生プラスチックを使用した医薬品ボトルの開発を確実にするための取り組みを強化しています。例えば、2024年1月、クリーンテクノロジーの主要企業であるLoop Industries, Inc.と、医療機器および医薬品包装の国際的プロバイダーであるBormioli Pharmaは、100%再生された新品同等品質のLoop PET樹脂を使用して開発された医薬品包装ボトルを発売しました。このような高品質な代替の医薬品包装は、製薬部門における持続可能な包装の新たな基準を確立し、そのようなソリューションの開発に向けた投資を促進しており、市場の拡大を支えています。

当レポートでは、世界の医薬品包装材料市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢と見通しなどを提供しています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 顧客の声

  • 市場の認知度と製品情報
  • ブランド認知度とロイヤルティ
  • 購入決定において考慮される要素
  • 購入頻度
  • 購入媒体

第5章 世界の医薬品包装材料市場の見通し(2017年~2031年)

  • 市場規模と予測
    • 金額
    • 数量
  • 包装タイプ別
    • 一次
    • 二次
    • 三次
  • 原材料別
    • プラスチック
    • 金属
    • ガラス
    • 紙、板紙
    • その他
  • ドラッグデリバリー別
    • 経口薬
    • 外用薬
    • 注射薬
    • 鼻腔
    • 眼科
    • 点滴薬
    • 経皮
    • その他
  • エンドユーザー別
    • 医薬品製造
    • 小売薬局
    • 受託包装
    • 施設薬局
  • 地域別
    • 北米
    • 南米
    • 欧州
    • アジア太平洋
    • 中東・アフリカ
  • 市場シェア:企業別(2023年)

第6章 世界の医薬品包装材料市場の見通し:地域別(2017年~2031年)

  • 北米
    • 市場規模と予測
    • 包装タイプ別
    • 原材料別
    • ドラッグデリバリー別
    • エンドユーザー別
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • イタリア
    • 英国
    • ロシア
    • オランダ
    • スペイン
    • トルコ
    • ポーランド
  • アジア太平洋
    • インド
    • 中国
    • 日本
    • オーストラリア
    • ベトナム
    • 韓国
    • インドネシア
    • フィリピン
  • 南米
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • 南アフリカ

第7章 サプライサイド分析

  • 生産能力:企業別
  • 生産:企業別
  • 運転効率:企業別
  • 主なプラントの所在地(最大25ヶ所)

第8章 市場マッピング(2023年)

  • 包装タイプ別
  • 原材料別
  • ドラッグデリバリー別
  • エンドユーザー別
  • 地域別

第9章 マクロ環境と産業構造

  • 需給分析
  • 輸入輸出分析
  • サプライチェーン分析
  • PESTEL分析
  • ポーターのファイブフォース分析

第10章 市場力学

  • 成長促進要因
  • 成長抑制要因(課題、抑制要因)

第11章 主要企業の情勢

  • マーケットリーダー上位5社の競合マトリクス
  • マーケットリーダー上位5社の市場収益分析(2023年)
  • 合併と買収/合弁事業(該当する場合)
  • SWOT分析(市場企業5社)
  • 特許分析(該当する場合)

第12章 価格分析

第13章 ケーススタディ

第14章 主要企業の見通し

  • Amcor plc
  • Berry Global Group, Inc.
  • Gerresheimer AG
  • Schott AG
  • AptarGroup Inc.
  • Catalent, Inc.
  • WestRock Company
  • Becton, Dickinson, and Company
  • Nipro Corporation
  • CCL Industries Inc.

第15章 戦略的推奨

第16章 当社について、免責事項

図表

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1.Global Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 2.Global Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 3.Global Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 4.Global Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 5.Global Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 6.Global Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 7.Global Pharma Packaging Materials Market Share (%), By Region, 2017-2031F
  • Figure 8.North America Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 9.North America Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 10.North America Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 11.North America Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 12.North America Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 13.North America Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 14.North America Pharma Packaging Materials Market Share (%), By Country, 2017-2031F
  • Figure 15.United States Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 16.United States Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 17.United States Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 18.United States Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 19.United States Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 20.United States Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 21.Canada Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 22.Canada Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 23.Canada Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 24.Canada Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 25.Canada Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 26.Canada Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 27.Mexico Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 28.Mexico Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 29.Mexico Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 30.Mexico Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 31.Mexico Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 32.Mexico Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 33.Europe Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 34.Europe Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 35.Europe Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 36.Europe Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 37.Europe Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 38.Europe Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 39.Europe Pharma Packaging Materials Market Share (%), By Country, 2017-2031F
  • Figure 40.Germany Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 41.Germany Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 42.Germany Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 43.Germany Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 44.Germany Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 45.Germany Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 46.France Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 47.France Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 48.France Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 49.France Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 50.France Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 51.France Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 52.Italy Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 53.Italy Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 54.Italy Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 55.Italy Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 56.Italy Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 57.Italy Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 58.United Kingdom Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 59.United Kingdom Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 60.United Kingdom Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 61.United Kingdom Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 62.United Kingdom Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 63.United Kingdom Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 64.Russia Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 65.Russia Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 66.Russia Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 67.Russia Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 68.Russia Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 69.Russia Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 70.Netherlands Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 71.Netherlands Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 72.Netherlands Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 73.Netherlands Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 74.Netherlands Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 75.Netherlands Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 76.Spain Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 77.Spain Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 78.Spain Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 79.Spain Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 80.Spain Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 81.Spain Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 82.Turkey Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 83.Turkey Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 84.Turkey Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 85.Turkey Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 86.Turkey Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 87.Turkey Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 88.Poland Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 89.Poland Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 90.Poland Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 91.Poland Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 92.Poland Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 93.Poland Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 94.South America Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 95.South America Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 96.South America Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 97.South America Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 98.South America Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 99.South America Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 100.South America Pharma Packaging Materials Market Share (%), By Country, 2017-2031F
  • Figure 101.Brazil Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 102.Brazil Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 103.Brazil Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 104.Brazil Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 105.Brazil Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 106.Brazil Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 107.Argentina Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 108.Argentina Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 109.Argentina Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 110.Argentina Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 111.Argentina Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 112.Argentina Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 113.Asia-Pacific Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 114.Asia-Pacific Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 115.Asia-Pacific Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 116.Asia-Pacific Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 117.Asia-Pacific Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 118.Asia-Pacific Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 119.Asia-Pacific Pharma Packaging Materials Market Share (%), By Country, 2017-2031F
  • Figure 120.India Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 121.India Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 122.India Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 123.India Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 124.India Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 125.India Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 126.China Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 127.China Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 128.China Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 129.China Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 130.China Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 131.China Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 132.Japan Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 133.Japan Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 134.Japan Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 135.Japan Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 136.Japan Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 137.Japan Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 138.Australia Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 139.Australia Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 140.Australia Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 141.Australia Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 142.Australia Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 143.Australia Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 144.Vietnam Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 145.Vietnam Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 146.Vietnam Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 147.Vietnam Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 148.Vietnam Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 149.Vietnam Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 150.South Korea Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 151.South Korea Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 152.South Korea Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 153.South Korea Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 154.South Korea Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 155.South Korea Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 156.Indonesia Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 157.Indonesia Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 158.Indonesia Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 159.Indonesia Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 160.Indonesia Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 161.Indonesia Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 162.Philippines Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 163.Philippines Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 164.Philippines Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 165.Philippines Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 166.Philippines Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 167.Philippines Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 168.Middle East & Africa Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 169.Middle East & Africa Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 170.Middle East & Africa Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 171.Middle East & Africa Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 172.Middle East & Africa Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 173.Middle East & Africa Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 174.Middle East & Africa Pharma Packaging Materials Market Share (%), By Country, 2017-2031F
  • Figure 175.Saudi Arabia Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 176.Saudi Arabia Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 177.Saudi Arabia Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 178.Saudi Arabia Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 179.Saudi Arabia Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 180.Saudi Arabia Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 181.UAE Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 182.UAE Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 183.UAE Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 184.UAE Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 185.UAE Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 186.UAE Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 187.South Africa Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 188.South Africa Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 189.South Africa Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 190.South Africa Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 191.South Africa Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 192.South Africa Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 193.By Packaging Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194.By Raw Material Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195.By Drug Delivery Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196.By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197.By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
目次
Product Code: MX11283

Global pharma packaging materials market is projected to witness a CAGR of 10.1% during the forecast period 2024-2031, growing from USD 121.61 billion in 2023 to USD 261.63 billion in 2031F. The growth of the market can be attributed to the expansion of the pharmaceutical sector and the increase in expenditure in the healthcare sector.

The rising requirement for drugs and medication is a major factor bolstering the requirement for pharma packaging materials. For instance, according to the estimates of Center for Disease Control and Prevention reviewed in November 2023, approximately 71.9% of physician office visits involve drug therapy and around 1 billion drugs are prescribed. The frequently prescribed classes of therapeutics include vitamins, analgesics, and antihyperlipidemic agents. The increased requirement is thus bolstering the demand for pharma packaging materials. The growing strictness of different regulatory bodies, such as FDA, towards pharmaceutical packaging is bolstering investments in pharma packaging materials, which in turn is positively influencing the global pharma packaging materials market expansion.

The increasing emphasis on the development of sustainable pharmaceutical packaging materials owing to rising environmental concerns is supporting the market's expansion. The augmenting efforts of various manufacturing companies to develop pharmaceutical packaging materials with technical recyclability further boost the market growth.

For instance, TerraCycle, a global leader in collecting and repurposing hard to recycle waste recognized Honeywell's Aclar Barrier Film Blisters as technically recyclable for PETG and PVC-based blisters. The film is a part of their Life Sciences portfolio and aids in protecting the drugs by providing moisture barrier protection to preserve the efficacy of the medicines and ensure the stability of the drug. Such achievements are supporting the expansion of the market as they provide methodologies for recycling multi-layer materials such as pharmaceutical blister packaging.

Expansion of Healthcare and Pharmaceutical Sectors Boosts Global Pharma Packaging Materials Market Growth

The increasing investments in the pharmaceutical and healthcare sector, along with advancements in manufacturing processes and technological innovations, provide lucrative growth opportunities to the market. For instance, Invest India estimated that the hospital sector in India will reach USD 219.2 billion (INR 18,348.78 billion) in revenue by the financial year 2027. The growth is expected to bolster the requirement for pharmaceutical packaging materials, supporting the expansion of the market.

The growth of the healthcare sector can be attributed to the rising investments by leading companies, increasing awareness about various benefits offered by the healthcare systems, rising income levels, and growing emphasis on health management. Due to the growth, the utilization of pharmaceutical products is augmenting, bolstering the demand for pharma packaging materials. The rising prevalence of various diseases and disorders further boosts the requirement for drugs and medications, among other pharmaceutical supplies, resulting in an increased demand for pharma packaging materials. These factors are heavily contributing to the growth of the market.

Increasing Emphasis on Development of Sustainable Pharma Packaging Provides Lucrative Growth Opportunities to the Market

Various pharmaceutical and healthcare companies across the globe are developing comprehensive sustainability packaging programs to reduce their carbon footprint and decrease their reliance on plastic across the packaging supply chain. Increased consumer demand for environment-friendly packaging products, owing to rising environmental consciousness, is further encouraging pharmaceutical companies to adopt sustainable packaging solutions and provide eco-friendly alternatives to consumers. To meet the increase in demand for sustainable packaging solutions, various leading pharmaceutical companies have boosted their investments in collaborations to reduce the negative environmental impact caused by their packaging. Such collaborations and efforts are providing lucrative growth opportunities to the market.

Moreover, due to growing concerns about the environment, leading providers of medical devices and pharmaceutical packaging are boosting their efforts to ensure the development of pharmaceutical bottles with 100% recycled plastic. For instance, in January 2024, Loop Industries, Inc., a leading clean technology company and Bormioli Pharma, an international provider of medical devices and pharmaceutical packaging, launched pharma packaging bottles that were developed using 100% recycled virgin-quality Loop PET resin. Such high-quality pharma packaging alternatives are aiding in establishing new standards for sustainable packaging in the pharmaceutical sector and bolstering investments towards developing such solutions, thus supporting the expansion of the market.

Asia-Pacific Accounts for Significant Market Share

The growth of the Asia-Pacific market can be attributed to the strong presence of key market players, the rapid expansion of the pharmaceutical sector, and increasing investments in the healthcare sector. The demand for pharma packaging materials is rising due to the increased requirement for different pharmaceutical products owing to rapid population growth. The increase in research and development activities in the pharmaceutical sector, coupled with the production of novel medications, is further bolstering the demand for pharma packaging materials in Asia-Pacific.

Additionally, the rapid expansion of the pharmaceutical sector supports market growth. For instance, Invest India estimates that the pharmaceutical market in the country will reach USD 130 billion by 2030. Moreover, India exports pharmaceutical products to over 200 countries, supplying approx. 25% of all medicines in the United Kingdom, around 40% of generic demand in the United States, and over 50% of Africa's requirement for generics. Additionally, 70% of WHOs vaccines are sourced from India. Thus, due to the growth in the requirement and export of different pharmaceutical products, the demand for pharma packaging materials is rising, boosting the market's growth.

Technological Advancements in Primary Packaging Aid Market Expansion

The increasing integration of radiofrequency identification in various packaging, such as prefilled syringes coupled with increased efforts towards development of counterfeit prevention mechanisms are supporting the growth of the market. For instance, the developments in printing techniques and 3D visualization are aiding in pushing the design boundaries of primary as well as secondary packaging, allowing companies to save time and money in development costs and material wastage. Such advancements will positively influence the growth of the market over the forecast period. Additionally, using primary packaging provides a compatible and safe barrier for medications. Due to it, the efforts to enhance the development of primary packaging are increasing, supporting the segment's expansion.

Pharmaceutical Manufacturing Will Boost Market Demand

The rising requirement for pharma packaging materials by the pharmaceutical manufacturing sector can be attributed to the increased demand for medications due to the expansion of the geriatric population and the growing prevalence of various diseases and disorders. According to WHO, by 2030, one in six individuals across the globe will be aged 60 or above, and by 2050, approximately 2.1 billion individuals will be 60 or older. The expansion of the geriatric population will bolster the demand for various pharmaceutical products as they are more prone to illnesses, propelling the requirement for pharma packaging materials and augmenting the growth of the market.

Additionally, the rapid expansion of pharmaceutical industry in various regions is further aiding the expansion of the market. For instance, the European Federation of Pharmaceutical Industries and Associations estimates that North America accounted for 49.1% of global pharmaceutical sales, while Europe accounted for 23.4%. Due to the rise in sales of pharmaceuticals, the demand for pharma packaging materials is rising, positively influencing the growth of the market.

Future Market Scenario (2024 - 2031F)

According to global pharma packaging materials market analysis, the market will witness significant growth over the forecast period owing to growing potential of automation, artificial intelligence, and blockchain technology for optimizing the traceability of finished products and streamlining the pharmaceutical packaging process. The requirement for intelligent packaging processes along with multiple packaging formats will witness an increase.

Furthermore, the utilization of pre-filled syringes and single-use vials that have the ability to accommodate a wider range of formulations and dosages and smaller volumes of medication will rise. The direct delivery of personalized treatment solutions to the patients will boost the demand for packaging materials that will protect the medications against various environmental factors. Thus, boosting the growth of the market and supporting the market expansion.

Additionally, due to the increasing emphasis on sustainability and burgeoning environmental crisis, various leading market players are actively investing towards the development of eco-friendly and biodegradable pharma packaging materials. Thus, providing lucrative growth opportunities to the market.

Key Players Landscape and Outlook

The increasing development of sustainable pharmaceutical packaging solutions will boost the growth of the market. For instance, high-barrier PVDC coating provided by Solvay provides an ultra-high water vapor barrier. It enables thin thermoforming films, aiding the pharma packaging material manufacturers to reduce their carbon footprint. The Diofan Ultra736's robust barrier properties allow for reduced coating thickness, with no negative effects on the performance of the package. The product contains no fluorine, allowing it to meet the regulatory requirements for direct pharmaceutical contact. Such product developments will aid the pharma packaging materials manufacturers in reducing their carbon footprint, positively influencing the growth of the market.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Voice of Customer

  • 4.1.Market Awareness and Product Information
  • 4.2.Brand Awareness and Loyalty
  • 4.3.Factors Considered in Purchase Decision
    • 4.3.1.Brand Name
    • 4.3.2.Quality
    • 4.3.3.Quantity
    • 4.3.4.Price
    • 4.3.5.Product Specification
    • 4.3.6.Form Specification
    • 4.3.7.Shelf Life
    • 4.3.8.Availability of Product
  • 4.4.Frequency of Purchase
  • 4.5.Medium of Purchase

5.Global Pharma Packaging Materials Market Outlook, 2017-2031F

  • 5.1.Market Size & Forecast
    • 5.1.1.By Value
    • 5.1.2.By Volume
  • 5.2.By Packaging Type
    • 5.2.1.Primary
      • 5.2.1.1.Plastic Bottles
      • 5.2.1.2.Caps and Closures
      • 5.2.1.3.Parenteral Containers
        • 5.2.1.3.1.Syringes
        • 5.2.1.3.2.Vials and Ampoules
        • 5.2.1.3.3.Others
      • 5.2.1.4.Blister Packs
      • 5.2.1.5.Prefillable Inhalers
      • 5.2.1.6.Pouches
      • 5.2.1.7.Medication Tubes
      • 5.2.1.8.Others
    • 5.2.2.Secondary
      • 5.2.2.1.Prescription Containers
      • 5.2.2.2.Pharmaceutical Packaging Accessories
    • 5.2.3.Tertiary
  • 5.3.By Raw Material
    • 5.3.1.Plastic
    • 5.3.2.Metal
    • 5.3.3.Glass
    • 5.3.4.Paper and Paperboards
    • 5.3.5.Others
  • 5.4.By Drug Delivery
    • 5.4.1.Oral Drugs
    • 5.4.2.Topicals
    • 5.4.3.Injectables
    • 5.4.4.Pulmonary
    • 5.4.5.Nasal
    • 5.4.6.Ocular/ Ophthalmic
    • 5.4.7.IV Drugs
    • 5.4.8.Transdermal
    • 5.4.9.Others
  • 5.5.By End-user
    • 5.5.1.Pharmaceutical Manufacturing
    • 5.5.2.Retail Pharmacy
    • 5.5.3.Contract Packaging
    • 5.5.4.Institutional Pharmacy
  • 5.6.By Region
    • 5.6.1.North America
    • 5.6.2.South America
    • 5.6.3.Europe
    • 5.6.4.Asia-Pacific
    • 5.6.5.Middle East & Africa
  • 5.7.By Company Market Share (%), 2023

6.Global Pharma Packaging Materials Market Outlook, By Region, 2017-2031F

  • 6.1.North America*
    • 6.1.1.Market Size & Forecast
      • 6.1.1.1.By Value
      • 6.1.1.2.By Volume
    • 6.1.2.By Packaging Type
      • 6.1.2.1.Primary
        • 6.1.2.1.1.Plastic Bottles
        • 6.1.2.1.2.Caps and Closures
        • 6.1.2.1.3.Parenteral Containers
          • 6.1.2.1.3.1.Syringes
          • 6.1.2.1.3.2.Vials and Ampoules
          • 6.1.2.1.3.3.Others
        • 6.1.2.1.4.Blister Packs
        • 6.1.2.1.5.Prefillable Inhalers
        • 6.1.2.1.6.Pouches
        • 6.1.2.1.7.Medication Tubes
        • 6.1.2.1.8.Others
      • 6.1.2.2.Secondary
        • 6.1.2.2.1.Prescription Containers
        • 6.1.2.2.2.Pharmaceutical Packaging Accessories
      • 6.1.2.3.Tertiary
    • 6.1.3.By Raw Material
      • 6.1.3.1.Plastic
      • 6.1.3.2.Metal
      • 6.1.3.3.Glass
      • 6.1.3.4.Paper and Paperboards
      • 6.1.3.5.Others
    • 6.1.4.By Drug Delivery
      • 6.1.4.1.Oral Drugs
      • 6.1.4.2.Topicals
      • 6.1.4.3.Injectables
      • 6.1.4.4.Pulmonary
      • 6.1.4.5.Nasal
      • 6.1.4.6.Ocular/ Ophthalmic
      • 6.1.4.7.IV Drugs
      • 6.1.4.8.Transdermal
      • 6.1.4.9.Others
    • 6.1.5.By End-user
      • 6.1.5.1.Pharmaceutical Manufacturing
      • 6.1.5.2.Retail Pharmacy
      • 6.1.5.3.Contract Packaging
      • 6.1.5.4.Institutional Pharmacy
    • 6.1.6.United States*
      • 6.1.6.1.Market Size & Forecast
        • 6.1.6.1.1.By Value
        • 6.1.6.1.2.By Volume
      • 6.1.6.2.By Packaging Type
        • 6.1.6.2.1.Primary
          • 6.1.6.2.1.1.Plastic Bottles
          • 6.1.6.2.1.2.Caps and Closures
          • 6.1.6.2.1.3.Parenteral Containers
          • 6.1.6.2.1.3.1.Syringes
          • 6.1.6.2.1.3.2.Vials and Ampoules
          • 6.1.6.2.1.3.3.Others
          • 6.1.6.2.1.4.Blister Packs
          • 6.1.6.2.1.5.Prefillable Inhalers
          • 6.1.6.2.1.6.Pouches
          • 6.1.6.2.1.7.Medication Tubes
          • 6.1.6.2.1.8.Others
        • 6.1.6.2.2.Secondary
          • 6.1.6.2.2.1.Prescription Containers
          • 6.1.6.2.2.2.Pharmaceutical Packaging Accessories
        • 6.1.6.2.3.Tertiary
      • 6.1.6.3.By Raw Material
        • 6.1.6.3.1.Plastic
        • 6.1.6.3.2.Metal
        • 6.1.6.3.3.Glass
        • 6.1.6.3.4.Paper and Paperboards
        • 6.1.6.3.5.Others
      • 6.1.6.4.By Drug Delivery
        • 6.1.6.4.1.Oral Drugs
        • 6.1.6.4.2.Topicals
        • 6.1.6.4.3.Injectables
        • 6.1.6.4.4.Pulmonary
        • 6.1.6.4.5.Nasal
        • 6.1.6.4.6.Ocular/ Ophthalmic
        • 6.1.6.4.7.IV Drugs
        • 6.1.6.4.8.Transdermal
        • 6.1.6.4.9.Others
      • 6.1.6.5.By End-user
        • 6.1.6.5.1.Pharmaceutical Manufacturing
        • 6.1.6.5.2.Retail Pharmacy
        • 6.1.6.5.3.Contract Packaging
        • 6.1.6.5.4.Institutional Pharmacy
    • 6.1.7.Canada
    • 6.1.8.Mexico

All segments will be provided for all regions and countries covered

  • 6.2.Europe
    • 6.2.1.Germany
    • 6.2.2.France
    • 6.2.3.Italy
    • 6.2.4.United Kingdom
    • 6.2.5.Russia
    • 6.2.6.Netherlands
    • 6.2.7.Spain
    • 6.2.8.Turkey
    • 6.2.9.Poland
  • 6.3.Asia-Pacific
    • 6.3.1.India
    • 6.3.2.China
    • 6.3.3.Japan
    • 6.3.4.Australia
    • 6.3.5.Vietnam
    • 6.3.6.South Korea
    • 6.3.7.Indonesia
    • 6.3.8.Philippines
  • 6.4.South America
    • 6.4.1.Brazil
    • 6.4.2.Argentina
  • 6.5.Middle East & Africa
    • 6.5.1.Saudi Arabia
    • 6.5.2.UAE
    • 6.5.3.South Africa

7.Supply Side Analysis

  • 7.1.Capacity, By Company
  • 7.2.Production, By Company
  • 7.3.Operating Efficiency, By Company
  • 7.4.Key Plant Locations (Up to 25)

8.Market Mapping, 2023

  • 8.1.By Packaging Type
  • 8.2.By Raw Material
  • 8.3.By Drug Delivery
  • 8.4.By End-user
  • 8.5.By Region

9.Macro Environment and Industry Structure

  • 9.1.Supply Demand Analysis
  • 9.2.Import Export Analysis
  • 9.3.Supply Chain Analysis
  • 9.4.PESTEL Analysis
    • 9.4.1.Political Factors
    • 9.4.2.Economic System
    • 9.4.3.Social Implications
    • 9.4.4.Technological Advancements
    • 9.4.5.Environmental Impacts
    • 9.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 9.5.Porter's Five Forces Analysis
    • 9.5.1.Supplier Power
    • 9.5.2.Buyer Power
    • 9.5.3.Substitution Threat
    • 9.5.4.Threat from New Entrant
    • 9.5.5.Competitive Rivalry

10.Market Dynamics

  • 10.1.Growth Drivers
  • 10.2.Growth Inhibitors (Challenges and Restraints)

11.Key Players Landscape

  • 11.1.Competition Matrix of Top Five Market Leaders
  • 11.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 11.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 11.4.SWOT Analysis (For Five Market Players)
  • 11.5.Patent Analysis (If Applicable)

12.Pricing Analysis

13.Case Studies

14.Key Players Outlook

  • 14.1.Amcor plc
    • 14.1.1.Company Details
    • 14.1.2.Key Management Personnel
    • 14.1.3.Products & Services
    • 14.1.4.Financials (As reported)
    • 14.1.5.Key Market Focus & Geographical Presence
    • 14.1.6.Recent Developments
  • 14.2.Berry Global Group, Inc.
  • 14.3.Gerresheimer AG
  • 14.4.Schott AG
  • 14.5.AptarGroup Inc.
  • 14.6.Catalent, Inc.
  • 14.7.WestRock Company
  • 14.8.Becton, Dickinson, and Company
  • 14.9.Nipro Corporation
  • 14.10.CCL Industries Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

15.Strategic Recommendations

16.About Us & Disclaimer